CST3 and colorectal carcinoma: We found that the creatinine/cystatin C ratio can be used as an effective prognostic stratification factor for CRC patients with normal CEA levels, suggesting that it can be used as a further prognostic stratification factor for CEA in the prognosis prediction of CRC patients.